Literature DB >> 11690731

Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome.

Nina Bohm-Starke1, Marita Hilliges, Gunilla Brodda-Jansen, Eva Rylander, Erik Torebjörk.   

Abstract

Vulvar vestibulitis syndrome (VVS) is a long lasting disorder of superficial dyspareunia in young women. Quantitative sensory testing, including mechanical and temperature pain thresholds and warm/cold difference limen (WCL), was performed in the vestibular mucosa in 22 women (mean age 25.0 years) with vestibulitis and 20 control subjects (mean age 25.6 years). The tests were carried out on days 7-11 of the menstrual cycle. Patients had allodynia to mechanical testing with von Frey filaments, 14.3+/-3.1mN in the symptomatic posterior area as compared with 158+/-33.5mN in healthy subjects, P<0.0001. The pain threshold to heat was 38.6+/-0.6 degrees C in patients and 43.8+/-0.8 degrees C in controls, P<0.0001. In addition, pain threshold to cold was 21.6+/-1.2 degrees C in patients whereas cooling down to 6 degrees C was usually not painful in controls. WCL was 4.9+/-0.5 degrees C in patients and 9.6+/-1.5 degrees C in healthy subjects, P<0.01. The results are compatible with the hypothesis that patients with VVS have an increased innervation and/or sensitization of thermoreceptors and nociceptors in their vestibular mucosa.

Entities:  

Mesh:

Year:  2001        PMID: 11690731     DOI: 10.1016/S0304-3959(01)00352-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  27 in total

Review 1.  [Interactions between itch and pain].

Authors:  M Schmelz
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

2.  Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia.

Authors:  Rufina Kim; Kerri-Lynn Kelly; Merle Olson; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

3.  Repeated variate stress in male rats induces increased voiding frequency, somatic sensitivity, and urinary bladder nerve growth factor expression.

Authors:  Liana Merrill; Susan Malley; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-08       Impact factor: 3.619

Review 4.  Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.

Authors:  Natalie O Rosen; Samantha J Dawson; Melissa Brooks; Susan Kellogg-Spadt
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

5.  Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative?

Authors:  Filippo Murina; Gianluigi Radici; Vanda Bianco
Journal:  MedGenMed       Date:  2004-12-08

6.  Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections.

Authors:  Lily A Arya; Gina M Northington; Tirsit Asfaw; Heidi Harvie; Anna Malykhina
Journal:  BJU Int       Date:  2011-11-30       Impact factor: 5.588

7.  Does Degree of Vulvar Sensitivity Predict Vulvodynia Characteristics and Prognosis?

Authors:  Barbara D Reed; Melissa A Plegue; Siobán D Harlow; Hope K Haefner; Ananda Sen
Journal:  J Pain       Date:  2016-10-24       Impact factor: 5.820

8.  Altered central sensitization in subgroups of women with vulvodynia.

Authors:  Zheng Zhang; Denniz A Zolnoun; Eric M Francisco; Jameson K Holden; Robert G Dennis; Mark Tommerdahl
Journal:  Clin J Pain       Date:  2011 Nov-Dec       Impact factor: 3.442

9.  Multimodal Vulvar and Peripheral Sensitivity Among Women With Vulvodynia: A Case-Control Study.

Authors:  Barbara D Reed; Ananda Sen; Sioban D Harlow; Hope K Haefner; Richard H Gracely
Journal:  J Low Genit Tract Dis       Date:  2017-01       Impact factor: 1.925

10.  Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse.

Authors:  E Rylander; A-L Berglund; C Krassny; B Petrini
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.